This product has the characteristics of promoting mucus elimination and dissolving secretions, which can promote the elimination of viscous secretions in the respiratory tract and reduce mucus retention, significantly promote expectoration, and improve respiratory conditions. When using this product for treatment, the patient's mucus secretion can be restored to normal, coughing and sputum volume are usually significantly reduced, and the surfactant on the respiratory mucosa can thus play its normal protective function.

Hyperosmotic dehydration, tissue dehydration and diuresis, reduces cerebrospinal fluid volume and reduces intracranial pressure

Supplements calories and has a certain dehydrating effect on tissues

Maintaining stable body fluid volume and osmotic pressure

Betahistine is a diamine oxidase inhibitor. It has a significant dilating effect on cerebrovascular and cardiovascular systems, especially on the conical artery system. It significantly increases the blood flow of the heart, brain and peripheral circulation, improves blood circulation, and lowers systemic blood pressure. In addition, it can increase the blood flow of the cochlea and vestibule, thereby eliminating inner ear vertigo, tinnitus and ear closure. It can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema. It can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and inhibit blood coagulation and ADP-induced platelet aggregation. It can prolong the time of thrombosis in vitro in rats and has a slight diuretic effect.

Strengthen the function of the brainstem reticular formation, especially the ascending reticular formation excitatory system which is closely related to consciousness; strengthen the function of the vertebral system and improve motor paralysis; improve cerebral circulation, promote brain metabolism by reducing cerebral blood flow resistance and increasing cerebral blood flow, and play a certain role in promoting brain function recovery and awakening.

This product is a new type of triazole antifungal drug that can specifically and effectively inhibit the synthesis of fungal sterols, that is, the synthesis of ergosterol, the main component of fungal cells. It also inhibits fungal peroxidase, leading to fungal death. Intravenous injection of this product is effective for various animal fungal infections, such as Candida infections (including systemic candidiasis and infections caused by immunosuppression in animals), Cryptococcus neoformans infections (including intracranial infections), Microsporum infections, and Trichophyton, Epidermophyton, Pityrosporum and other infections.